4//SEC Filing
OBRIEN MORGAN E 4
Accession 0001209191-22-060105
CIK 0001304492other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 6:36 PM ET
Size
8.7 KB
Accession
0001209191-22-060105
Insider Transaction Report
Form 4
Anterix Inc.ATEX
OBRIEN MORGAN E
DirectorVice Chairman of the Board
Transactions
- Award
Stock Option (Right to Buy)
2022-12-02+154,203→ 154,203 totalExercise: $49.39Exp: 2032-12-02→ Common Stock (154,203 underlying)
Footnotes (1)
- [F1]25% of the option shares vest and become exercisable on December 2, 2023, with the remaining option shares vesting in 3 equal annual installments thereafter.
Issuer
Anterix Inc.
CIK 0001304492
Entity typeother
Related Parties
1- filerCIK 0000937846
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 6:36 PM ET
- Size
- 8.7 KB